MedTrace Logo

A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer

NCT04443985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2022-05-20

No results posted yet for this study

Summary

Due to colorectal cancer is the fourth most common malignancy in the world. Some patients had present locally advance stage and need to preoperative concurrent chemoradiation (CCRT) before radical surgery. But predictor for pathologic complete response (pCR) after preoperative CCRT remain unclear.

Objectives: To identify possible factor for predict of pCR of rectal cancer after preoperative CCRT.

Conditions

  • Rectum Cancer

Sponsors & Collaborators

  • Ramathibodi Hospital

    collaborator OTHER

  • Mahidol University

    lead OTHER

Principal Investigators

  • Chairat Supsamutchai, MD · Ramathibodi Hospital, Mahidol University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-07-20
Completion
2020-08-10

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04443985 on ClinicalTrials.gov